A patient with well-documented hypereosinophilic syndrome who underwent successful allogeneic bone marrow transplantation (BMT) is reported. This therapeutic modality should be considered in patients who fail standard therapy, End-organ damage may be reversible to some extent, and should not exclude patients from consideration of BMT.